Share Issue/Capital Change • Jun 23, 2008
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
The Annual General Meeting of RaySearch Laboratories AB (publ), which was held on May 22, 2008, passed the following resolutions, among others.
For the purpose of achieving a number of shares that is appropriate for the company, the Meeting decided to increase the number of shares in the company through a split of each share into three (3) shares, whereby the number of the shares in the company increases to 34,282,773, of which 12,638,724 Series A and 21,644,049 Series B, each with a quota value of SEK 0.50. In addition, the Meeting authorized the Board to decide on the record date for the split and to take the other measures necessary to implement the split.
The Board of Directors has decided that the record date for the split is Friday, June 27, 2008.
The final trading day for the RaySearch share prior to the split will be Tuesday, 24 June 2008. The new split shares will be traded on the OMX Nordic Exchange Stockholm, Wednesday, 25 June, 2008.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch's products are sold through license agreements with leading partners such as Philips, Varian, Nucletron, IBA Dosimetry and TomoTherapy. Eight products have been released to date and RaySearch's software is used at over 1,300 clinics in more than 30 countries. In addition, existing license agreements cover more than 15 other products that are scheduled to be launched in the coming years. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the SmallCap segment on the OMX Nordic Exchange Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.